K Sugimachi

Angiographically undetected small hepatocellular carcinoma: Clinicopathological characteristics, follow‐up and treatment

K. Shirabe, T. Kanematsu, K. Takenaka, 1989, Hepatology.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Y Wang, Mike Clarke, Donald A. Berry, 2005, The Lancet.

Clinical management of recurrent hepatocellular carcinoma after primary resection

H. Higashi, K. Sugimachi, K. Takenaka, 1988, The British journal of surgery.

Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin

M. Shimada, K. Shirabe, M. Shimada, 1997, The British journal of surgery.

Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection

Y. Ikeda, K. Shirabe, M. Shimada, 1998, Hepatology.

A 5‐year experience of lipiodolization: Selective regional chemotherapy for 200 patients with hepatocellular carcinoma

K. Hasuo, T. Kanematsu, K. Takenaka, 1989, Hepatology.

Tamoxifen for early breast cancer: an overview of the randomised trials

Mike Clarke, Luc Bijnens, Michael Gnant, 1998, The Lancet.

Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume.

T. Utsunomiya, K. Shirabe, M. Shimada, 1999, Journal of the American College of Surgeons.